Merck defeats incomes requirements, raises sales outlook on sturdy need for top medicines like Keytruda - CNBC

.Merck defeats revenues desires, raises sales outlook on solid demand for leading medicines like Keytruda CNBCMerck &amp Co. (MRK US) Beats Revenue Forecasts as Keytruda Sales Increase BloombergMerck Inventory: Pharma Titan Posts Powerful End Results, However Expectation Tumbles Short Real estate investor's Company DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats profit and purchases assumptions amid Keytruda advantage, yet delivers mixed full-year outlook MarketWatch.